• Log in
Greater Manchester Medicines Management Group - GMMMG logo
  • Home
    • Homepage
    • News Summary
    • Consultations
  • Joint Formulary
    • BNF Chapters
    • Formulary Requests
  • RAG/DNP
    • RAG/DNP List
    • Paediatric RAG/DNP List
    • RAG Submissions
  • Shared Care
    • Approved Shared Care Protocols
  • GMMMG Guidance
    • Clinical guidance and pathways
    • Medicines and devices recommendations
    • Information leaflets for primary care prescribers
    • High cost drugs
    • Prescribing policies
    • Operational policies
  • Meetings
    • Membership and Terms of Reference
    • Decision Summaries
    • GMMMG Meetings
    • Clinical Reference Group
    • GMMMG Process Documents
    • Subgroup Meetings Archives
Home » Amber » Page 2

Amber

Risperidone

Oral Second Generation (Atypical) Antipsychotics for Adults – Review due 21/4/18

Risperidone (Risperdal Consta®)

Risperidone Long-acting antipsychotic injection

Riluzole

Riluzole for Amyotrophic Lateral Sclerosis (a form of Motor Neurone Disease)

Quetiapine

Oral Second Generation (Atypical) Antipsychotics for Adults – Review due 21/4/18

Penicillamine

Paliperidone palmitate

Paliperidone Long-acting antipsychotic injection

Paliperidone

Olanzapine

Oral Second Generation (Atypical) Antipsychotics for Adults – Review due 21/4/18

Naltrexone

Status depends on local commissioning arrangements for substance misuse

Mycophenolate

To remain amber until repatriation occurs

Posts navigation

Older posts
Newer posts

Follow GMMMG on Twitter

  • Terms and Conditions
  • Contact
  • About us
  • RSS Feed